Anavex Life Sciences Corp (AVXL)

[frrol]

They were marginally positive and statistically significant. So it got approved. The bar is low, which is good for us. We have lot of participants on DPZ. Hopefully we'll show improvement over baseline for them vs placebo, and also for the DPZ naive patients over baseline vs placebo.

Side note: it's so good we have blinded placebo controls. It's much more reliable than an SOC historical control. It makes even marginal stat with results that much more reliable. They're such an important trial tool.